Identification of novel immunoregulatory molecules in human thymic regulatory CD4 +CD25 + T cells by phage display

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Porto, Georgia ^a   Giordano, Ricardo J ^a,c   Marti, Luciana C ^d   Stolf, Beatriz ^a   Pasqualini, Renata ^c   Arap, Wadih ^c   Kalil, Jorge ^a,b   Coelho, Verônica ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Institute for Investigation in Immunology   (Brazil)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR FOXP3; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; CD4 ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR ALPHA;

ARTICLE; BINDING AFFINITY; CD4+ CD25+ T LYMPHOCYTE; CELL ISOLATION; CELL SELECTION; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NEWBORN; PHAGE DISPLAY; PROTEIN EXPRESSION; RECEPTOR BINDING; REGULATORY T LYMPHOCYTE; SCHOOL CHILD; SEQUENCE ANALYSIS; THYMOCYTE; BACTERIOPHAGE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; T LYMPHOCYTE; THYMUS;

ANTIGENS, CD4; BACTERIOPHAGES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; RECEPTORS, CALCITRIOL; T-LYMPHOCYTES; THYMUS GLAND;

EID: 79960933495     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021702     Document Type: Article

References (47)

1. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M, (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155: 1151-1164.
2. Itoh M, Takahashi T, Sakaguchi N, Kuniyasu Y, Shimizu J, et al. (1999) Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 162: 5317-5326.
3. Fontenot JD, Gavin MA, Rudensky AY, (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4: 330-336.
4. Cederbom L, Hall H, Ivars F, (2000) CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol 30: 1538-1543.
5. Elias KM, Laurence A, Davidson TS, Stephens G, Kanno Y, et al. (2008) Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 111: 1013-1020.
6. Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itoh M, et al. (1998) Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 10: 1969-1980.
7. Powrie F, Read S, Mottet C, Uhlig H, Maloy K, (2003) Control of immune pathology by regulatory T cells. Novartis Found Symp 252: 92-98; discussion 98-105, 106-114.
8. Sakaguchi S, Miyara M, Costantino CM, Hafler DA, (2010) FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10: 490-500.
9. Velappan N, Fisher HE, Pesavento E, Chasteen L, D'Angelo S, et al. (2010) A comprehensive analysis of filamentous phage display vectors for cytoplasmic proteins: an analysis with different fluorescent proteins. Nucleic Acids Res 38 (4): e22.
10. Curotto de Lafaille MA, Lafaille JJ, (2009) Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 30: 626-635.
11. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, et al. (2005) Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22: 329-341.
12. Levings MK, Roncarolo MG, (2000) T-regulatory 1 cells: a novel subset of CD4 T cells with immunoregulatory properties. J Allergy Clin Immunol 106: S109-112.
13. Zhang X, Koldzic DN, Izikson L, Reddy J, Nazareno RF, et al. (2004) IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int Immunol 16: 249-256.
14. Wang J, Ioan-Facsinay A, van der Voort EI, Huizinga TW, Toes RE, (2007) Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol 37: 129-138.
15. Thornton AM, Korty PE, Tran DQ, Wohlfert EA, Murray PE, et al. (2010) Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol 184: 3433-3441.
16. Arap W, Kolonin MG, Trepel M, Lahdenranta J, Cardo-Vila M, et al. (2002) Steps toward mapping the human vasculature by phage display. Nat Med 8: 121-127.
17. Giordano RJ, Cardo-Vila M, Lahdenranta J, Pasqualini R, Arap W, (2001) Biopanning and rapid analysis of selective interactive ligands. Nat Med 7: 1249-1253.
18. Lewis VO, Ozawa MG, Deavers MT, Wang G, Shintani T, et al. (2009) The interleukin-11 receptor alpha as a candidate ligand-directed target in osteosarcoma: consistent data from cell lines, orthotopic models, and human tumor samples. Cancer Res 69: 1995-1999.
19. Trepel M, Arap W, Pasqualini R, (2002) In vivo phage display and vascular heterogeneity: implications for targeted medicine. Curr Opin Chem Biol 6: 399-404.
20. Yang Y, Zizheng W, Tongxin D, (2008) Mouse thymus targeted peptide isolated by in vivo phage display can inhibit bioactivity of thymus output in vivo. J Biomol Screen 13: 968-974.
21. Mathieu C, Adorini L, (2002) The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol Med 8: 174-179.
22. Nakajima S, Hsieh JC, MacDonald PN, Galligan MA, Haussler CA, et al. (1994) The C-terminal region of the vitamin D receptor is essential to form a complex with a receptor auxiliary factor required for high affinity binding to the vitamin D-responsive element. Mol Endocrinol 8: 159-172.
23. Ito M, Yuan CX, Malik S, Gu W, Fondell JD, et al. (1999) Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. Mol Cell 3: 361-370.
24. Tagami T, Lutz WH, Kumar R, Jameson JL, (1998) The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators. Biochem Biophys Res Commun 253: 358-363.
25. Baudino TA, Kraichely DM, Jefcoat SC Jr, Winchester SK, Partridge NC, et al. (1998) Isolation and characterization of a novel coactivator protein, NCoA-62, involved in vitamin D-mediated transcription. J Biol Chem 273: 16434-16441.
26. Sims RJ 3rd, Mandal SS, Reinberg D, (2004) Recent highlights of RNA-polymerase-II-mediated transcription. Curr Opin Cell Biol 16: 263-271.
27. Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM, (2008) Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 324: 23-33.
28. Vieira PL, Christensen JR, Minaee S, O'Neill EJ, Barrat FJ, et al. (2004) IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J Immunol 172: 5986-5993.
29. Kang I, Kim SH, Lee W-w, Kang SW, Lee JS, (2010) 1,25-dihyroxyvitamin D3 enhances the activity of the FOXP3 gene in human CD4+ T cells through directly binding to putative VDRE sites in the FOXP3 gene. J Immunol 184: 49.42.
30. Nezbedova P, Brtko J, (2004) 1alpha,25-dihydroxyvitamin D3 inducible transcription factor and its role in the vitamin D action. Endocr Regul 38: 29-38.
31. Mucida D, Cheroutre H, (2007) TGFbeta and retinoic acid intersect in immune-regulation. Cell Adh Migr 1: 142-144.
32. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, et al. (2007) Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317: 256-260.
33. Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, Hall J, Sun CM, et al. (2007) A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 204: 1757-1764.
34. Zurita AJ, Troncoso P, Cardo-Vila M, Logothetis CJ, Pasqualini R, et al. (2004) Combinatorial screenings in patients: the interleukin-11 receptor alpha as a candidate target in the progression of human prostate cancer. Cancer Res 64: 435-439.
35. Dias-Neto E, Nunes DN, Giordano RJ, Sun J, Botz GH, et al. (2009) Next-generation phage display: integrating and comparing available molecular tools to enable cost-effective high-throughput analysis. PLoS One 4: e8338.
36. Zhao G, Simpson RU, (2010) Membrane localization, Caveolin-3 association and rapid actions of vitamin D receptor in cardiac myocytes. Steroids 75: 555-559.
37. Mizwicki MT, Keidel D, Bula CM, Bishop JE, Zanello LP, et al. (2004) Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1alpha,25(OH)2-vitamin D3 signaling. Proc Natl Acad Sci U S A 101: 12876-12881.
38. Huhtakangas JA, Olivera CJ, Bishop JE, Zanello LP, Norman AW, (2004) The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 alpha,25(OH)2-vitamin D3 in vivo and in vitro. Mol Endocrinol 18: 2660-2671.
39. Penna G, Adorini L, (2000) 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164: 2405-2411.
40. Adorini L, Daniel KC, Penna G, (2006) Vitamin D receptor agonists, cancer and the immune system: an intricate relationship. Curr Top Med Chem 6: 1297-1301.
41. Norman AW, (2006) Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology 147: 5542-5548.
42. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, et al. (2001) 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 167: 4974-4980.
43. Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, et al. (2001) Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 167: 1945-1953.
44. Jeffery LE, Burke F, Mura M, Zheng Y, Qureshi OS, et al. (2009) 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol 183: 5458-5467.
45. Adorini L, Penna G, (2008) Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 4: 404-412.
46. Penna G, Amuchastegui S, Laverny G, Adorini L, (2007) Vitamin D receptor agonists in the treatment of autoimmune diseases: selective targeting of myeloid but not plasmacytoid dendritic cells. J Bone Miner Res 22 (Suppl 2): V69-73.
47. Adorini L, (2002) Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. Int Immunopharmacol 2: 1017-1028.